The investment is part of a 5-year plan to invest $10 billion in Canadian communities by 2030BRAMPTON, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Today, Loblaw Companies Limited (TSX: L, “Loblaw” or the “Company”), Canada’s food and pharmacy leader, announced that it will spend $2.4 billion in 2026 to expand and renovate its store network, enhance its supply chain capabilities, and create jobs for people all across Canada. At a time when Canadians are struggling with affordability and access to healthcare s ...

Walgreens cuts workforce after private equity buyout, Bloomberg News reports | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A sign advertises flu, pneumonia, and shingles vaccine shots at a Walgreens pharmacy in Miami, Florida, U.S. September 4, 2025 REUTERS/Marco Bello [Purchase Licensing Rights, opens new tab]- Companies[Amazon.com Inc]Follow[Walmart Inc]FollowFeb 19 (Reuters) - Pharmacy chain Walgreens is laying off over 600 em ...

Corporate Performance - The Dow Jones Industrial Average increased by approximately 0.7%, while the S&P 500 gained roughly 0.2%, indicating a positive trend in blue-chip stocks [2] - Investors are analyzing quarterly earnings reports from companies such as Coca-Cola and CVS Health, with Ford being a notable focus after market close [4] Economic Indicators - December's retail sales data showed that retail spending remained "virtually unchanged" from the previous month, signaling a slowdown in consumer spending compared to November's month-on-month growth of 0.6% [3] - The upcoming January jobs report is highly anticipated, especially following recent signs of softening in the labor market [4] Market Trends - Gold and bitcoin are under investor scrutiny as they attempt to stabilize after a significant pullback last week, with gold slightly declining after starting the week above $5,000, while bitcoin traded below $69,000 before a minor recovery [5]

Corporate Performance - The Dow Jones Industrial Average increased by approximately 0.7%, while the S&P 500 gained roughly 0.2%, indicating a positive trend in blue-chip stocks [2] - Investors are analyzing quarterly earnings reports from companies such as Coca-Cola and CVS Health, with Ford being a notable focus after market close [4] Economic Indicators - December's retail sales data showed that retail spending remained "virtually unchanged" from the previous month, signaling a slowdown in consumer spending compared to November's month-on-month growth of 0.6% [3] - The upcoming January jobs report is highly anticipated, especially following recent signs of softening in the labor market, with the Consumer Price Index due on Friday to assess inflation pressures [4] Market Trends - Gold and bitcoin are under investor scrutiny as they attempt to stabilize after a significant pullback last week, with gold slightly declining after starting the week above $5,000, while bitcoin traded below $69,000 before a minor recovery [5]

CVS Health on Tuesday reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that impressed investors, signaling steady progress in the health-care giant's turnaround plan. "'24 was a tough year for the company. So '25 righted the ship," CVS CFO Brian Newman said in an interview. CVS, which operates one of the largest pharmacy chains in the U.S., sees full-year profit coming in between $7 to $7.20 per share. That's in line with the $7.17 per share that analy ...

CVS Health Corporation (NYSE:CVS) is flat on Wednesday. The shares dropped by almost 15% yesterday after it was reported that Medicare was proposing rates that are well below expectations. • What’s driving CVS shares today?If the shares continue to trend lower, they may find support around $70. They may even rally off this level. This is why CVS is the Stock of the Day.Successful traders understand which price levels in a market are important. These are called support and resistance levels.If a stock is tre ...

Group 1 - Loblaw Companies Limited will release its 2025 fourth quarter and full year results on February 25, 2026, at approximately 6:30 a.m. (ET) [1] - A conference call will follow the results release at 10:00 a.m. (ET), along with an audio webcast [1] - The audio webcast will be available for replay for 12 months after the live event [2] Group 2 - Loblaw is Canada's food and pharmacy leader and the largest retailer in the nation, providing a wide range of products and services [3] - The company operates more than 2,500 corporate franchised and Associate-owned locations, employing over 220,000 full- and part-time employees [3] - Loblaw's purpose is to prioritize the needs and well-being of Canadians, facilitating one billion transactions annually in its stores [4] Group 3 - Loblaw offers a diverse range of services including grocery, pharmacy, health and beauty, apparel, general merchandise, financial services, and wireless mobile products [3][4] - The company has over 1,100 grocery stores that cater to various market segments, from discount to specialty [4] - Loblaw operates nearly 1,400 Shoppers Drug Mart® and Pharmaprix® locations, along with pharmacies in close to 500 grocery stores [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码：002727 股票简称：一心堂 公告编号：2026-010号 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日。 2、业绩预告情况：预计净利润为正值且属于同向上升50%以上情形 （1）以区间数进行业绩预告的 四、风险提示 本次业绩预告是公司财务部门初步核算的结果，具体财务数据将在公司2025年年度报告中详细披露。敬 请广大投资者审慎决策，注意投资风险。 特此公告。 一心堂药业集团股份有限公司 单位：万元 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。公司已就本次业绩预告情况与年报审计会计师事务所进行沟通， 公司与会计师事务所对于本次业绩预告不存在分歧。 三、业绩变动原因说明 公司门店拓展方面，截至2025年12月31日，公司拥有直营连锁门店11,112家，全年净减少386家。2025 年，通过精细化管理和一系列措施，优化资源配置，确保费用支出与业务目标相匹配，从而提高公司运 营效率和盈利能力。 2025年 ...

扬子晚报网1月22日讯(记者姜婧仪通讯员赵君)为解决老人"买药难、用药难"问题，南京雨花台区市场监管局将"精准助老"药事服务延伸至 社区"最后一米"。通过在各街道(园区)筛选因病致贫的困难老年群体作为重点帮扶对象，并依托辖区药店建立"一对一"结对帮扶机制，由 执业药师定期上门提供个性化药学服务，将专业与温情送到老人心坎上，让夕阳更红、晚年更暖。 上门服务 目前，雨花台区"精准助老"药事服务已实现8个街道园区全覆盖，筑康、高济再康、益丰、海王星辰等企业积极响应，共设立8个服务站 点，构建起一张严密的"护老网"。从"坐堂问诊"转向"上门服务"，执业药师们不仅提供科普宣讲、建档随访等专业药事服务，更延伸至生 活温情关怀。截至2025年底，精准助老项目累计出动人员1035人次，上门服务481人次，开展药品安全讲座21次，惠及居民千余人，真正 打通了健康服务的"最后一公里"。 低保户周阿姨有多年的高血压糖尿病史，还有脑梗、胃癌病史，每日需服用8种药品，因用药结构复杂，周阿姨不仅常常记混、吃错，而 且容易发生合并用药不良反应。对此，结对的何药师为周阿姨量身定制了"个人用药档案"，把复杂的用药方案化繁为简，详细标注了每种 ...

Core Insights - The S&P 500 is experiencing unprecedented concentration, with the 10 largest companies accounting for about 40% of the index's weight, significantly above the long-term average of approximately 20% [1][2] Group 1: Market Concentration - Analysts express concern that high concentration may lead to lower S&P 500 returns over the next decade compared to a less concentrated market [2] - The top 10 stocks in the S&P 500 account for 35% of the index's earnings, making the current weight of 40% reasonable [6] Group 2: Investment Alternatives - The Invesco S&P 500 Revenue ETF tracks the S&P 500 but weights stocks based on trailing-12-month revenue, imposing a 5% weight cap on individual stocks [3][5] - The Invesco S&P 500 Equal Weight ETF measures performance by giving equal weight to all constituents, eliminating concentration risk entirely [8][9] Group 3: Performance and Fees - The Invesco S&P 500 Revenue ETF has returned 545% since its inception in 2008, while the S&P 500 has returned 630%, indicating potential for continued underperformance due to concentration risk [6][10] - The Invesco S&P 500 Revenue ETF has a relatively high expense ratio of 0.39%, while the Invesco S&P 500 Equal Weight ETF has a lower expense ratio of 0.2%, making it a more cost-effective option for investors seeking exposure without concentration risk [7][11]